Stock Earnings

Question 1

Protara Therapeutics Inc 的关键财务报表是什么？

Accepted Answer

根据最新的财务报表（Form-10K），Protara Therapeutics Inc 的总资产为 $181，净loss为 $-45

Question 2

TARA 的关键财务比率是什么？

Accepted Answer

Protara Therapeutics Inc 的流动比率是 12.92，净利 margin 为 0，每股销售为 $0。

Question 3

Protara Therapeutics Inc 的收入按细分市场或地理位置如何划分？

Accepted Answer

Currently Protara Therapeutics Inc data is not available.

Question 4

Protara Therapeutics Inc 是否盈利？

Accepted Answer

no，根据最新的财务报表，Protara Therapeutics Inc 的净loss为 $-45

Question 5

Protara Therapeutics Inc 有负债吗？

Accepted Answer

yes，Protara Therapeutics Inc 的负债为 14

Question 6

Protara Therapeutics Inc 的流通股有多少？

Accepted Answer

Protara Therapeutics Inc 的总流通股为 35.04

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	19	17	18	20	26	22
Research & Development	37	--	24	16	21	11
Operating Expenses	57	49	44	37	47	34
Other Non Operating Income (Expenses)	--	4	--	--	--	--
Pretax Income	-50	-45	-40	-65	-47	-33
Income Tax Expense	--	--	--	--	--	--
Net Income	-50	-45	-40	-65	-47	-33
Net Income Growth	25%	13%	-38%	38%	42%	136%
Shares Outstanding (Diluted)	42.27	21	11	11.26	11.23	7.23
Shares Change (YoY)	101%	91%	-2%	0%	55%	1,346%
EPS (Diluted)	-1.19	-2.14	-3.63	-5.86	-4.21	-4.7
EPS Growth	-38%	-41%	-38%	39%	-10%	-84%
Free Cash Flow	-44	-35	-37	-26	-35	-24
Free Cash Flow Per Share	-1.04	-1.66	-3.36	-2.3	-3.11	-3.31
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-57	-49	-44	-37	-47	-34
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-57	-49	-44	-37	-47	-34
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Protara Therapeutics Inc (TARA) Price